Apuli Maricel

Apuli Maricel is listed in filings as Chief Accounting Officer at BridgeBio Pharma, Inc. - Common Stock. This profile follows SEC Form 4 activity through May 19, 2026, including sale activity. Recent filings connect the profile to BridgeBio Pharma, Inc. - Common Stock (BBIO). The current snapshot covers public activity from Mar 21, 2025 to May 19, 2026. Reported amounts are shown as $311.7K to $132.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.